The most commonly reported side effects include: Nausea : Affecting 12% to 24% of patients with type 2 diabetes and 24% to 31% in weight management trials Diarrhea : 12% to 17% in diabetes trials and 18% to 23% in weight management trials Decreased appetite : 5% to 10% of patients Vomiting : 5% to 10% in diabetes trials and 8% to 12% in weight management trials Constipation : 5% to 7% in diabetes trials and 16% to 17% in weight management trials Dyspepsia : 5% to 9% of patients Abdominal pain : 5% to 9% of patients Alopecia (hair loss) : Reported in weight management trials These symptoms are typically mild to moderate in severity, occur most commonly during dose escalation, and tend to diminish over time as patients develop tolerance
They are often a complement
In addition, Ive consistently been selected as a Castle Connolly Top Doctor for the last thirteen years
In the chemotherapy recovery model, mice received doxorubicin followed by FOXO4-DRI treatment to assess recovery acceleration
Various external factors could trigger the release of drugs from these engineered liposomes, for instance, variation in the pH or enzymatic activity (134136)
Light exposure: No Light Exposure-Picture Courtesy: Light Sources Cyanocobalamin is active ingredient of vitamin b12 injection for dogs and it is light-sensitive